Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Shanghai RAAS Blood Products Co., Ltd.
—
Shanghai RAAS Blood Products Co., Ltd. is led by CEO Jun Xu, employs 4,045 people, headquartered in Shanghai, CN, publicly traded since 2008.
Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) stock trades at $4.86 with a market capitalization of $32.57B. The stock is valued at a price-to-earnings (P/E) ratio of 27.44, price-to-book of 1.01, price-to-sales of 4.93. Over the past 52 weeks the stock has ranged between $4.18 and $6.97, and currently trades 30.3% below its 52-week high. It pays a dividend yielding 0.95%.
On profitability, Shanghai RAAS Blood Products Co., Ltd. generates a return on equity (ROE) of 3.73%, an operating margin of 14.50%, a net profit margin of 18.29%.
The balance sheet shows a debt-to-equity ratio of 0.11 (debt below half of shareholders' equity), a current ratio of 4.49.
002252.SZ has an average daily trading volume of 57,397,928 shares, a beta of 0.33 (historically less volatile than the overall market), 6.59B shares outstanding.
Official website: www.raas-corp.com
Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) — frequently asked questions
What is Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) stock price today?
Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) is currently trading at $4.86, down 2.99% today.
What is 002252.SZ P/E ratio?
Shanghai RAAS Blood Products Co., Ltd.'s P/E ratio is 27.44. This is between 15x and 30x, around the typical market average of roughly 18-22x.
What is 002252.SZ return on equity (ROE)?
Shanghai RAAS Blood Products Co., Ltd.'s return on equity (ROE) is 3.73%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Shanghai RAAS Blood Products Co., Ltd.'s market cap?
Shanghai RAAS Blood Products Co., Ltd. has a market capitalization of $32.57B.
Does 002252.SZ pay a dividend?
Yes. Shanghai RAAS Blood Products Co., Ltd. currently yields 0.95%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 002252.SZ carry?
Shanghai RAAS Blood Products Co., Ltd. has a debt-to-equity ratio of 0.11. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 002252.SZ's profit margin?
Shanghai RAAS Blood Products Co., Ltd. reports a net profit margin of 18.29% — the share of revenue left after every cost, including tax and interest.
What sector is 002252.SZ in?
Shanghai RAAS Blood Products Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 002252.SZ listed on?
Shanghai RAAS Blood Products Co., Ltd. trades on SHZ under the ticker 002252.SZ.
What is 002252.SZ's 52-week range?
Over the last year Shanghai RAAS Blood Products Co., Ltd. has traded between $4.18 and $6.97.
Related — Stocks
Popular Stocks
Screens 002252.SZ currently matches
On the figures above, Shanghai RAAS Blood Products Co., Ltd. passes the filters for 12 of our ready-made screens, among them Low Debt Stocks, Penny Stocks, Large Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.